EMERGENCY SURGICAL TREATMENT OF GIANT BILATERAL METACHRONUS KRUKENBERG TUMORS OF SIGMOID ORIGIN: A CASE REPORT

  • Ștefania Petrescu Obstetrics and Gynecology Department, “Bucur” Maternity, “Saint John” Hospital, Bucharest, Romania
  • Irina Bondoc General Surgery Department, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania
  • Andrei Văcărașu General Surgery Department, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania & "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Mara Mardare General Surgery Department, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania & "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Alin Burlacu General Surgery Department, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania
  • Marius Zamfir General Surgery Department, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania & "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Luminița Udrea Intensive Care Unit, "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania
  • Carolina Negrei "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Maria Alexandra Barbu "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Bogdan Tănase "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania & "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
  • Octav Ginghină "Prof. dr. Alexandru Trestioreanu" Institute of Oncology Bucharest, Romania & "Carol Davila" University of Medicine and Pharmacy Bucharest, Romania
Keywords: Krukenberg tumors, sigmoid tumor, intestinal occlusion

Abstract

Krukenberg tumors are metastatic malignancies of the ovaries that consist of mucin-rich signet-ring adenocarcinomas. The stomach is the primary site in most cases (70%), while carcinomas of the colon, appendix and breast (mostly invasive lobular carcinomas) are the next most common sites. We present the case of a 56-year-old female with a history of a stage IV M1 hep sigmoid adenocarcinoma who underwent neoadjuvant chemotherapy. During this time a tumoral mass in the lower abdomen kept developing and growing bigger and bigger, causing subocclusive symptoms by external compression, such as intermittent constipation, cramping pains with lack of flatus and episodes of vomiting. A CT scan of the abdomen was performed, which showed a uterus of large dimensions, a myometrium of inhomogeneous structure with multiple nodules that could not be separated from the adnexal masses and tumoral masses in both ovaries with important growth in dimensions, currently measuring 16/12/15 cm (trans/a-p/c-c) for the right ovary and 14/12/11 (trans/a-p/c-c) cm for the left ovary, in contact with each other cranially and extended up to the subhepatic land mesogastrium level. A total hysterectomy with bilateral anexectomy was performed, in order to improve patient’s condition and to help her continue her chemotherapy. The postoperative recovery went smooth, the patient resumed her transit 6 days after the intervention. Krukenberg tumors are rare ovarian metastatic tumors, that can be more aggressive than the primary tumor itself and can even endanger patient’s life due to their acute symptoms, for which they may require per primam surgical intervention before tackling the primary tumor.

References

1. Kubeček O, Laco J, Špaček J, Petera J, Kopecký J, Kubečková A, Filip S. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastasis. 2017 Jun;34(5):295-307
2. Al-Agha OM, Nicastri AD. An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med. 2006 Nov;130(11):1725-30
3. Sakio R, Ito H, Ota G, Tahara M, Yano T, Koinuma K, Horie H, Lefor AK, Yamamoto H, Sata N. Metachronous Krukenberg tumor from adenocarcinoma in a Meckel's diverticulum: a case report. J Surg Case Rep. 2021 Aug;2021(8):rjab374.
4. Osama M. Al-Agha, Anthony D. Nicastri, An In-depth Look at Krukenberg Tumor: An Overview Arch Pathol Lab Med (2006) 130 (11): 1725–1730.
5. Lionetti, R., De Luca, M., Travaglino, A. et al. Treatments and overall survival in patients with Krukenberg tumor. Arch Gynecol Obstet 300, 15–23 (2019). https://doi.org/10.1007/s00404-019-05167-z
6. Hamasaki S, Fukunaga Y, Nagayama S, Fujimoto Y, Akiyoshi T, Nagasaki T, Ueno M. Decision-making in postoperative chemotherapy for ovarian metastasis from colorectal cancer: a retrospective single-center study. World J Surg Oncol. 2022 Feb 1;20(1):28. doi: 10.1186/s12957-022-02498-1. PMID: 35105353; PMCID: PMC8805307.
7. Nomura M, Tei M, Nishida K, Mori S, Yasuyama A, Yoshikawa Y, Tamai K, Hamakawa T, Takiuchi D, Tsujie M, Akamaru Y. Aggressive surgical intervention may improve prognosis in patients with ovarian metastasis from colorectal cancer. Langenbecks Arch Surg. 2023 Aug 16;408(1):313. doi: 10.1007/s00423-023-03060-7. PMID: 37582897.
8. Chen, C., Wang, D., Ge, X. et al. Prognostic factors for ovarian metastases in colorectal cancer patients. World J Surg Onc 19, 220 (2021). https://doi.org/10.1186/s12957-021-02305-3
9. Xu, K.Y., Gao, H., Lian, Z.J. et al. Clinical analysis of Krukenberg tumours in patients with colorectal cancer—a review of 57 cases. World J Surg Onc 15, 25 (2017). https://doi.org/10.1186/s12957-016-1087-y
10. Al-Busaidi IS, Bailey T, Dobbs B, Eglinton TW, Wakeman CJ, Frizelle FA. Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival. ANZ J Surg. 2019;89(9):1091–6.
11. Benaaboud, I., M.Ghazli, M.Kerroumi, andA.Mansouri. Krukenberg tumor: 9 cases report [in French]J Gynecol Obstet Biol Reprod (Paris)2002. 31:365–370.
12. Kikkawa, F., K.Shibata, and K.Ino.et al. Preoperative findings in nongynecologic carcinomas metastasizing to the ovaries. Gynecol Obstet Invest 2002. 54:221–227.
13. Kim, H. K., D. S.Heo, Y. J. Bang, and N. K.Kim. Prognostic factors of Krukenberg's tumor. Gynecol Oncol 2001. 82:105–109.
14. Sugimoto, Y., K.Endo, and H.Sakahara. et al. Sequential measurement of serum CA 125 levels in Krukenberg's tumor [in Japanese].Gan No Rinsho 1985. 31:1893–1897.
15. Liao YC, Ou YC, Wu CH, Fu HC, Tsai CC, Lin H. CA125 normalization within 60 days as an independent prognostic factor for patients with advanced epithelial ovarian cancer. Cancer Biomark. 2021;32(4):559-567. doi: 10.3233/CBM-210156. PMID: 34397404.
Published
2023-12-24